Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT01655927
Eligibility Criteria:
Inclusion Criteria:
* Patients who agree to participate by giving informed consent
* Eligible previously untreated patients with resectable brain tumor.
Exclusion Criteria:
* Patients with previous thromboembolic events.
* Patients with coagulopathy or anticoagulation therapy. (Abnormal PT, PTT)
* Patients with impaired renal function (Creatinine \>1.1mg/dl)
* Patients with known contraindications to fibrinolytic treatment.
* Patients receiving rejection therapy.
* Patients with abnormal liver function.
* Known allergies to Tranexamic Acid.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01655927
Study Brief:
Protocol Section:
NCT01655927